SILVER SPRING, MD —The US Food and Drug Administration has expanded the June 2017 onsite field correction issued for Datascope/Maquet intra-aortic balloon pumps (IABPs) to a class I recall, the agency ...
Datascope/Maquet have initiated a worldwide recall of certain intra-aortic balloon pump (IABP) systems to address potential electrical test failures. The action involves CS100, CS100i, and CS300 IABPs ...
SILVER SPRING, MD — Datascope Corp/Maquet has initiated a worldwide "field correction" of certain intra-aortic balloon pump (IABP) systems to address potential electrical test failures, a MedWatch ...
— Datascope Corp./Maquet initiated a voluntary worldwide field correction of some of its intra-aortic balloon pumps (IABPs) due to a potential mechanical failure of the fan assembly associated with ...
The US Food and Drug Administration (FDA) on Tuesday designated Getinge’s Maquet/Datascope recall of intra-aortic balloon pumps (IABPs) as Class I after five patient deaths were reported since 2016.
The FDA has disclosed over 60 additional safety reports relating to intra-aortic balloon pumps manufactured by Maquet and Datascope, including two patient deaths, following a Class I recall this past ...
The US Food and Drug Administration (FDA) said Tuesday that since notifying physicians of particular intra-aortic balloon pump (IABP) device failures last November, two more patients have died and one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results